To the Editor: We believe that the ALLHAT authors1 inappropriately emphasized their results for heart
failure, although it was only 1 component of a secondary composite outcome.
This focus on heart failure previously led to early termination of the doxazosin
arm from the trial.2
Long-term Cardiovascular Consequences of Diuretics vs Calcium Channel
Blockers vs Angiotensin-Converting Enzyme Inhibitors. JAMA. 2003;289(16):2066. doi:10.1001/jama.289.16.2066-c